Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
1
V&V of Computational
Software to Predict the
Durability of Cardiac
Pacemaker Leads
May 19, 2015
Sanjeev Kulkarni, Animesh Dey, Robert
G. Tryon
© Copyright 2015 VEXTEC Corporation - All rights reserved
2
Talk Outline
1. Introduction
2. VLM Related to VVUQ
3. VEXTEC VLM Overview
4. Cardiac Leads Example
5. Nitinol Stent Example
6. MDDT Pilot Program
© Copyright 2015 VEXTEC Corporation - All rights reserved
3
Who is VEXTEC?
Founded in 2000: Over $25 million from the
United States Department of Defense
Innovative Research programs for
Technology Development
Proprietary Software and Seven Patents:
Virtual Life Management® (VLM®)
generates VIRTUAL TWIN®
Customers: Federal Government and
Industries (Aerospace, Automotive,
Electronics, Energy, MEDICAL DEVICES)
Value Proposition: Help companies
improve products and reduce cost
• New products to market quickly
• Improve reliability of existing products
• Reduce physical and prototype testing
requirements
• Forecast product durability and
manage product life cycle risk
Business Model: Hybrid – Consulting
Services, Software Licensing and Training
VEXTEC accepted into FDA’s
Medical Device Development
Tool (MDDT) pilot Program
© Copyright 2015 VEXTEC Corporation - All rights reserved
4
Uncertainty Management
Virtual Twin® representation of Uncertainty
Propagation across multiple levels of a system
• A probabilistic multi-disciplinary uncertainty
management analytical tool that links
computational models
• How will changing the input uncertainty of
the analysis impact the uncertainty in the
results?
• Can the uncertainty be updated based on
actual usage and observed damage state?
• What is the sensitivity to uncertainty?
Model 1
Model 2
Model 3
© Copyright 2015 VEXTEC Corporation - All rights reserved
5
Uncertainty Management
How general is this Uncertainty Management
Tool?
• General Tool –
– Virtual (In Silico) Clinical Trial
– Post Market Surveillance
– Therapy Effectiveness and Limits
Virtual
Patient
Device or
Therapy
Physician or
Process
© Copyright 2015 VEXTEC Corporation - All rights reserved
6
Uncertainty Management
Simulate the motion of a large number of
interacting spherical particles through tube
with a taper – Collaboration with CD-ADAPCO.
• Tapered Tube – Human Vasculature - Virtual
Patient
• Interacting Spherical Particles – Drug
Eluting Beads Delivered To Target Site –
Device / Therapy
• Random Motion of Spherical Particles –
Process
VLM framework captures the random
statistical nature of the problem to generate
the associated uncertainty scenarios.
© Copyright 2015 VEXTEC Corporation - All rights reserved
7
COU: MP35N Cardiac Leads
• Simulation of two test conditions –
Displacements A” and B”
• Cycling between maximum displacement and
0 displacement
• Cycling to 1E10 cycles and Runout
(suspension) if no failure
• Measured difference in maximum Von-Mises
stress between Conditions 1 and 2
Condition 1: A” Von Mises Stress; Max Stress=XX ksi
Condition 2: B” Von Mises Stress; Max Stress=YY ksi
Cond1: A”+/-a”Cond2: B”+/-b”
© Copyright 2015 VEXTEC Corporation - All rights reserved
8
Virtual Twin® of a cardiac / defibrillator lead design – Estimate fatigue life
• Sensitivity of uncertainty in input variables and
• Sensitivity of modeling approximations .
Flow of the design analysis:
• Manufacturing process model provides residual stress
• Structural analysis provides stresses model
• Microstructural material model predicts fatigue
Sources of uncertainty:
• Coil winding uncertainty
• Predicted residual stress uncertainty
• Structural geometry uncertainty
• Loads and boundary conditions uncertainty
• FEA mesh size uncertainty
• Material microstructure uncertainty
Cumulative Probability Distribution Function (CDF):
• Cycles to failure considering all uncertainties vs. actual test results
• Fatigue durability results are highly sensitive to uncertainty in residual
stress
• Simulations performed at different residual stress levels
• Good correlation for a calibrated value of residual stress
COU: MP35N Cardiac Leads
© Copyright 2015 VEXTEC Corporation - All rights reserved
9
Yes
Revise
Appropriate
Model or Experiment
Reality of Interest
(Component, Subassembly, Assembly, or System)
Conceptual
Mode
Mathematical Model
Acceptable
Agreement?
Next Reality of Interest in the Hierarchy
Abstraction
Mathematical
Modeling
Physical Model
Computational Model Experiment Design
Simulation Results Experimental Data
Simulation Outcomes Experimental Outcomes
Physical
Modeling
Implementation
Calculation
Uncertainty Quantification
Implementation
Experimentation
Uncertainty Quantification
Preliminary
Calculations
Quantitative
Comparison
No
Validation
Code Verification
Calculation
Verification
ASME
V&V 10 -
2006 Fig 4
VEXTEC VLM VEXTEC VLM
© Copyright 2015 VEXTEC Corporation - All rights reserved
10
ASME V&V 40 – Draft – Figure 2
VLM can be used to explore the region outside the Validation Domain
as well as at the edges (or even beyond) the CM&S assumptions
© Copyright 2015 VEXTEC Corporation - All rights reserved
11
Execute pre-
defined
M&S and
V&V plan
YES
Is the CM&S
credible for
COU?
PurposeDefine
COUAssess
Model
Risk
Establish
Credibility
Threshold
Establish
Work
plan for
VV
Is the plan
Achievable ?
Document M&S
And VV plan
and findings
No
No
YES
PIRTExisting
VV DataM&S
Plan
ASME V&V 40 – Draft – Figure 3
VLM can play a Key Role in each step
of the Credibility Assessment
Strategy especially in the
Execution Step – where
Uncertainty Quantification is
important
© Copyright 2015 VEXTEC Corporation - All rights reserved
12
ASME V&V 40 – Draft – Table1
Draft refers to “Uncertainty” 31 times and “Sensitivity” 12 times – both
implying increased level of credibility and VLM can address the
uncertainty management and design sensitivity considerations
Credibility Factors
Verification Validation
Applicability
Code Solution Model ComparatorOutput
Assessment
So
ftw
are
Qu
ali
ty A
ss
ura
nc
e
Nu
me
ric
al A
lgo
rith
m
Ve
rifi
cati
on
Dis
cre
tiza
tio
n E
rro
r
Us
e E
rro
r
Nu
me
ric
al S
olv
er
Err
or
Sys
tem
Co
nfi
gu
rati
on
Sys
tem
Pro
pe
rtie
s
Bo
un
da
ry C
on
dit
ion
s
Go
ve
rnin
g E
qu
ati
on
s
Sa
mp
le C
ha
rac
teri
za
tio
n
Co
ntr
ol O
ve
r Te
st
Co
nd
itio
ns
Me
as
ure
me
nt
Un
ce
rta
inty
Eq
uiv
ale
nc
y o
f in
pu
t a
nd
ou
tpu
t ty
pe
s
Rig
or
of
Ou
tpu
t C
om
pa
ris
on
Re
leva
nc
e o
f th
e
Qu
an
titi
es o
f In
tere
st
Ap
pli
ca
bil
ity t
o
the
Co
nte
xt
of
Us
e
© Copyright 2015 VEXTEC Corporation - All rights reserved
13
How the VLM Process Compares with
Conventional Methods?
VLM approach
predicts failures
Fatigue strength is traditionally
determined by testing VEXTEC’s view of component,
grains & damage
Conventional view of component10
60,000 75,000 lbs. persquare inch (psi)
Load Appliedto Shaft
Load BearingCapacity of Shaft
Percent
of Shafts
Shaft Failures
© Copyright 2015 VEXTEC Corporation - All rights reserved
14
VLM Predicts How, When, Where, and Why
Damage Occurs
Design & Stress Life & Where & Why
Standard Industry Analysis VLM Analysis
© Copyright 2015 VEXTEC Corporation - All rights reserved
15
VLM: Grain – FEA – Component – Fleet
ComponentDesign
Configuration
Material
Configuration
VLM
Computational
Processing
Mapping the
Elements
Component
Simulation
Fleet
Simulation
© Copyright 2015 VEXTEC Corporation - All rights reserved
16
VLM: Grain – FEA – Component – Fleet
Tooth Life: 15,932 cycles
Failure Cause: Defects
VLM Integration for
Entire Component
1st Virtual Twin
Gear Simulated
Component Life:
14,334 cycles
17,561 24,793
27,943
22,229
25,34218,961
22,113
Repeat Sequence
for Each Tooth
Integrate VLM
Results with FEA
Run 1,000 SimulationsVT1, VT2, VT3 … VT1,000
© Copyright 2015 VEXTEC Corporation - All rights reserved
17
Grain Size
Particle Size
J. E. Schaffer: Masters Thesis, Purdue, 2007
Residual Stress
Cardiac Leads – Material Model
© Copyright 2015 VEXTEC Corporation - All rights reserved
18
Near-initiation, cracked TiN particle
Chevron crack-initiating feature
J. E. Schaffer: Masters Thesis, Purdue, 2007
Nucleation
Crack front arrest at microstructural features.
Small Crack Growth
Striation spacing at crack front
Cardiac Leads – Material Model
© Copyright 2015 VEXTEC Corporation - All rights reserved
19
Cardiac Leads – Material Model
© Copyright 2015 VEXTEC Corporation - All rights reserved
20
COU: MP35N Cardiac Leads
• Simulation of two test conditions –
Displacements A” and B”
• Cycling between maximum displacement and
0 displacement
• Cycling to 1E10 cycles and Runout
(suspension) if no failure
• Measured difference in maximum Von-Mises
stress between Conditions 1 and 2
Condition 1: A” Von Mises Stress; Max Stress=XX ksi
Condition 2: B” Von Mises Stress; Max Stress=YY ksi
Cond1: A”+/-a”Cond2: B”+/-b”
© Copyright 2015 VEXTEC Corporation - All rights reserved
21
Cardiac Leads – VLM Simulation
© Copyright 2015 VEXTEC Corporation - All rights reserved
22
Virtual Twin® of a cardiac / defibrillator lead design – Estimate fatigue life
• Sensitivity of uncertainty in input variables and
• Sensitivity of modeling approximations .
Flow of the design analysis:
• Manufacturing process model provides residual stress
• Structural analysis provides stresses model
• Microstructural material model predicts fatigue
Sources of uncertainty:
• Coil winding uncertainty
• Predicted residual stress uncertainty
• Structural geometry uncertainty
• Loads and boundary conditions uncertainty
• FEA mesh size uncertainty
• Material microstructure uncertainty
Cumulative Probability Distribution Function (CDF):
• Cycles to failure considering all uncertainties vs. actual test results
• Fatigue durability results are highly sensitive to uncertainty in residual
stress
• Simulations performed at different residual stress levels
• Good correlation for a calibrated value of residual stress
COU: MP35N Cardiac Leads
© Copyright 2015 VEXTEC Corporation - All rights reserved
23
• Define geometry and stress with FEA
• Define microstructure with metallography
• Run Simulation
• Calibrate to residual stress profile with experimental data
Cardiac Leads – VLM Simulation
© Copyright 2015 VEXTEC Corporation - All rights reserved
24
• Virtual Design of
Experiments
• Applied displacement
• Residual stress profile
• Inclusion size
distribution
• Top durability drivers • Residual Stress – 10%
improvement yields 60% improvement in mean total life
• Inclusion Size – 50% smaller inclusion size yields 25% improvement in mean total life
• Inclusion Density- 50% lower inclusion density; No significant impact
• Trade-off threshold exists between residual stress and inclusion size
…
Cardiac Leads – VLM Simulation
© Copyright 2015 VEXTEC Corporation - All rights reserved
25
Cardiac Leads: Summary and Outcomes
Summary
• Simulated fatigue buckling test under 2 load conditions
• Virtual DOE consisted of 9600 individual coil simulations
Outcomes / Next Steps
• Sensitivity study around particle size, density and residual stress
• Determined residual stress to be a calibrated value - new knowledge
• Developed Insights - Design alternatives, Material substitution, Vendor management
• Potential - Sensitivity analysis, Design trade studies, Supplier controls, Design optimization
• Add Realism – Coiling Simulation for Residual Stresses
VDOE Results for Residual Stress
© Copyright 2015 VEXTEC Corporation - All rights reserved
26
• Evaluate Endoscopic Nitinol Stent to
calculate the effect of metallurgical
cleanliness on the fatigue life.
• Stent subject to fatigue cycles at a high
level of displacement to simulate
coughing..
• Two different materials (2 suppliers) with
different inclusion sizes and population
densities were evaluated using VLM.
COU: Endoscopic NiTi Airway Stent
© Copyright 2015 VEXTEC Corporation - All rights reserved
27
• Check out versus
– Published data
– Life
– Mechanisms
– Initiation type and size
• Data available for 3 mean
strains and various
alternating strains
Lin, Z et. al.; JMEP ASM International; Nov 2010Specimens cut from stents
Fracture Surface- failure at inclusion
Airway Stent – Material Model
© Copyright 2015 VEXTEC Corporation - All rights reserved
28
Airway Stent – Material Model
© Copyright 2015 VEXTEC Corporation - All rights reserved
29
Simulated Mean Cycles to Stent Failure
Airway Stent – VLM Simulation
© Copyright 2015 VEXTEC Corporation - All rights reserved
30
Simulated -3σ Cycles to Stent Failures and is an
indicator for early failure
Airway Stent – VLM Simulation
© Copyright 2015 VEXTEC Corporation - All rights reserved
32
VEXTEC has been selected into the Medical Device Development
Tools (MDDT) Pilot Program
MDDT – Cardiac Leads
Chronology• Medical Device Development Tools (MDDT) –
Draft Guidance - FDA – November 2013
• MDDT Pilot Program – Announced August 2014 – Began Accepting Nominations September 2014
• VEXTEC – Submitted in November 2014 and FDA sent Acceptance in December 2014
Highlights• VEXTEC VLM at a mature stage of
development
• FDA recognizes that VLM meets a key public health need – Major Efficiencies to be gained in Device Development and Evaluation Time
• VEXTEC currently working with OEMs, Software Vendors and FDA staff
• Seeking Partners / Collaborators.
© Copyright 2015 VEXTEC Corporation - All rights reserved
33
Summary / Takeaways
• Virtual Life Management and Virtual Twin represent a general
framework that incorporates systems realism including
uncertainty management and design sensitivity
• The framework supports key aspects of VVUQ standards –
ASME V&V 10 – 2006 and proposed ASME V&V 40
• A Cardiac Pacemaker Leads implementation was shown as an
example with key insights
– Ability to Virtually Simulate 10000 Bench Tests
– Study sensitivity of Microstructural Parameters and Residual
Stresses on Component Life
– Evaluate of Significant Outcomes – Design Alternatives,
Material Substitution and Vendor Management
– Demonstrate Potential for Major Gains in terms of time and
cost of Design Development and Evaluation
• Nitinol Airway Stent example compares results for two different
material suppliers
• VLM Methodology into FDA’s Medical Device Development Tool
(MDDT) Pilot program
© Copyright 2015 VEXTEC Corporation - All rights reserved
34
VLM software is applicable throughout a product’s life cycle,
constantly growing in capability and value
Thank you
© Copyright 2015 VEXTEC Corporation - All rights reserved